Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that safety and efficacy ...

A study reveals that lutein, present in fruit and vegetables, improves vision and protects the skin, which promotes new ...

Long-term stabilizing of retinal exudation and fluid accumulation contributes to brolucizumab’s efficacy in managing wet age-related macular degeneration (AMD). Visual prognosis could be improved when ...

OT asked the experts what delegates can expect to hear in clinical imaging, from skills development to applications of the latest techniques, at 100% Optical 2025 ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

Previous research has shown that voretigene neparvovec administered subretinally early in childhood for RPE65-mediated ...

Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.

The slit-lamp binocular macular biomicroscopy demonstrates that ... the neurosensory retina and the retinal pigment epithelial layer. [13] The sensory retinal elevation associated with this ...